3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
1
Surgery
1
Sarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Ductal Adenocarcinoma
1
Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer
1
Multiple Myeloma
1
Medulloblastoma
1
Lung Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
HER2-positive Breast Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Cancer Invasive
1
Interventions
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Platinum
3
Cisplatin
3
Cetuximab
3
1,2-diaminocyclohexaneplatinum II citrate
3
(225)Ac-DOTA-c(RGDyK)
3
pembrolizumab
2
Radiotherapy, Intensity-Modulated
2
Immunoglobulin G
2
Disulfides
2
Biopsy
2
ipatasertib
1
durvalumab
1
cabozantinib
1
atezolizumab
1
Surveys and Questionnaires
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Nivolumab
1
Docetaxel
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hypopharyngeal Neoplasms
×
Neoadjuvant Therapy
×
30 days
×
Clear all
No trials found.